Combined Tumor and Immune Signals from Genomes or Transcriptomes Predict Outcomes of Checkpoint Inhibition in Melanoma

The authors analyzed whole-exome and bulk RNA sequencing of tumors from new and published cohorts of 189 and 178 patients with melanoma receiving checkpoint blockade, respectively.